
Ensuring Response and Tolerable Dose Are Crucial in RCC
Daniel M. Geynisman, MD Chief, Division of Genitourinary Medical Oncology Associate Professor, Department of Hematology/Oncology Fox Chase Medical Center – Temple Health Philadelphia, PA DISCUSSION QUESTION What efficacy end points are the most …